https://www.selleckchem.com/pr....oducts/2-bromohexade
Symptomatic macromastia causes physical and psychological problems that can lead to restrictions in the patients' social and working lives and a reduced quality of life. Associated medical treatments also have a considerable impact on health-care costs. Several studies have assessed these costs, but the total disease costs of macromastia have never been evaluated on the basis of real-world data. The data for 76 patients who underwent reduction mammoplasty between 2008 and 2016 were collected using a two-part questionnai
Мне нравится
Комментарий
Перепост
